Neurotech Provides Update on BLA for NT-501 as a Treatment for Macular Telangiectasia Type 2 (MacTel) 

About Us Science & Technology Clinical Patients News Careers Publications Contact Us Supplier Code of Conduct Policy Accessibility Statement Privacy Policy